Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II Evaluation Of Temsirolimus Combination With Carboplatin And Paclitaxel Followed By Temsirolimus Consolidation As First-Line Therapy In The Treatment Of Stage III-IV Clear Cell Carcinoma Of The Ovary.
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209